Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-08

FDA Approved: BALSALAZIDE DISODIUM — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves balsalazide disodium as a generic product under an original ANDA by Zydus Lifesciences Limited for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BALSALAZIDE DISODIUM (balsalazide disodium)

Snippet

ORIG AP for BALSALAZIDE DISODIUM (BALSALAZIDE DISODIUM)